Pharmacological Properties of DOV 315,090, an ocinaplon metabolite
{{output}}
Background: Compounds targeting the benzodiazepine binding site of the GABAA-R are widely prescribed for the treatment of anxiety disorders, epilepsy, and insomnia as well as for pre-anesthetic sedation and muscle relaxation. It ... ...